Cancer Research AACR Legacy Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kiuru, M.
Right arrow Articles by Aaltonen, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kiuru, M.
Right arrow Articles by Aaltonen, L. A.
[Cancer Research 62, 4554-4557, August 15, 2002]
© 2002 American Association for Cancer Research

Advances in Brief

Few FH Mutations in Sporadic Counterparts of Tumor Types Observed in Hereditary Leiomyomatosis and Renal Cell Cancer Families1

Maija Kiuru2, Rainer Lehtonen2, Johanna Arola, Reijo Salovaara, Heikki Järvinen, Kristiina Aittomäki, Jari Sjöberg, Tapio Visakorpi, Sakari Knuutila, Jorma Isola, Brett Delahunt, Riitta Herva, Virpi Launonen, Auli Karhu and Lauri A. Aaltonen3

Departments of Medical Genetics [M. K., R. L., R. S., K. A., S. K., V. L., A. K., L. A. A.] and Pathology [J. A., R. S.], Biomedicum Helsinki or Haartman Institute, University of Helsinki, FIN-00014 Helsinki, Finland; Departments of Surgery [H. J.] and Obstetrics and Gynecology [J. S.], Helsinki University Central Hospital, FIN-00290 Helsinki, Finland; Institute of Medical Technology, University of Tampere and Tampere University Hospital, FIN-33014 Tampere, Finland [T. V., J. I.]; Department of Pathology, University of Otago, Wellington, New Zealand [B. D.]; and Department of Pathology, Oulu University Hospital, FIN-90220 Oulu, Finland [R. H.]

Loss of function mutations in the fumarate hydratase (fumarase, FH) gene were recently identified as the cause for dominantly inherited uterine and cutaneous leiomyomas and renal cell cancer. To further evaluate the role of FH in tumorigenesis, we screened FH mutations from tumor types seen in hereditary leiomyomatosis and renal cell cancer mutation carriers—41 uterine and 10 cutaneous leiomyomas, 52 renal cell carcinomas, 53 sarcomas, 29 prostate carcinomas, and 15 lobular breast carcinomas. Few mutations were detected. Biallelic inactivation of FH was found in one uterine leiomyosarcoma, one cutaneous leiomyoma, and one soft tissue sarcoma. Whereas the two former lesions were shown to originate from a germ-line mutation, the soft tissue sarcoma is to our knowledge the first example of purely somatic inactivation of FH in tumors.




This article has been cited by other articles:


Home page
 Arch DermatolHome page
L. Stewart, G. M. Glenn, P. Stratton, A. M. Goldstein, M. J. Merino, M. A. Tucker, W. M. Linehan, and J. R. Toro
Association of Germline Mutations in the Fumarate Hydratase Gene and Uterine Fibroids in Women With Hereditary Leiomyomatosis and Renal Cell Cancer
Arch Dermatol, December 1, 2008; 144(12): 1584 - 1592.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
J. C. Hodge and C. C. Morton
Genetic heterogeneity among uterine leiomyomata: insights into malignant progression
Hum. Mol. Genet., April 15, 2007; 16(R1): R7 - R13.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
H J Lehtonen, M Kiuru, S K Ylisaukko-oja, R Salovaara, R Herva, P A Koivisto, O Vierimaa, K Aittomaki, E Pukkala, V Launonen, et al.
Increased risk of cancer in patients with fumarate hydratase germline mutation
J. Med. Genet., June 1, 2006; 43(6): 523 - 526.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
S. Vanharanta, P. J. Pollard, H. J. Lehtonen, P. Laiho, J. Sjoberg, A. Leminen, K. Aittomaki, J. Arola, M. Kruhoffer, T. F. Orntoft, et al.
Distinct expression profile in fumarate-hydratase-deficient uterine fibroids
Hum. Mol. Genet., January 1, 2006; 15(1): 97 - 103.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
P.J. Pollard, J.J. Briere, N.A. Alam, J. Barwell, E. Barclay, N.C. Wortham, T. Hunt, M. Mitchell, S. Olpin, S.J. Moat, et al.
Accumulation of Krebs cycle intermediates and over-expression of HIF1{alpha} in tumours which result from germline FH and SDH mutations
Hum. Mol. Genet., August 1, 2005; 14(15): 2231 - 2239.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. Matyakhina, R. J. Freedman, I. Bourdeau, M.-H. Wei, S. G. Stergiopoulos, A. Chidakel, M. Walther, M. Abu-Asab, M. Tsokos, M. Keil, et al.
Hereditary Leiomyomatosis Associated with Bilateral, Massive, Macronodular Adrenocortical Disease and Atypical Cushing Syndrome: A Clinical and Molecular Genetic Investigation
J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3773 - 3779.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
M R Morris, E Maina, N V Morgan, D Gentle, D Astuti, H Moch, T Kishida, M Yao, P Schraml, F M Richards, et al.
Molecular genetic analysis of FIH-1, FH, and SDHB candidate tumour suppressor genes in renal cell carcinoma
J. Clin. Pathol., July 1, 2004; 57(7): 706 - 711.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
R. Lehtonen, M. Kiuru, S. Vanharanta, J. Sjoberg, L.-M. Aaltonen, K. Aittomaki, J. Arola, R. Butzow, C. Eng, K. Husgafvel-Pursiainen, et al.
Biallelic Inactivation of Fumarate Hydratase (FH) Occurs in Nonsyndromic Uterine Leiomyomas but Is Rare in Other Tumors
Am. J. Pathol., January 1, 2004; 164(1): 17 - 22.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. K. Khoo, K. Kahnoski, J. Sugimura, D. Petillo, J. Chen, K. Shockley, J. Ludlow, R. Knapp, S. Giraud, S. Richard, et al.
Inactivation of BHD in Sporadic Renal Tumors
Cancer Res., August 1, 2003; 63(15): 4583 - 4587.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
P Laiho, T Hienonen, J-P Mecklin, H Jarvinen, A Karhu, V Launonen, and L A Aaltonen
Mutation and LOH analysis of ACO2 in colorectal cancer: no evidence of biallelic genetic inactivation
J. Med. Genet., May 1, 2003; 40(5): e73 - 73.
[Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S.-Y. Lee, Y. Obata, M. Yoshida, E. Stockert, B. Williamson, A. A. Jungbluth, Y.-T. Chen, L. J. Old, and M. J. Scanlan
Immunomic analysis of human sarcoma
PNAS, March 4, 2003; 100(5): 2651 - 2656.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
R Lehtonen, M Kiuru, A Rokman, T Ikonen, J M Cunningham, D J Schaid, M Matikainen, N N Nupponen, A Karhu, O-P Kallioniemi, et al.
No fumarate hydratase (FH) mutations in hereditary prostate cancer
J. Med. Genet., March 1, 2003; 40(3): e19 - 19.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.